Aller au contenu principal
Profil bibliographique

Arjun Narayan Ajmer Jayaswal

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

24Publications signalées
1043Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Liver Disease Diagnosis and TreatmentLiver Disease and TransplantationHepatocellular Carcinoma Treatment and PrognosisSystemic Sclerosis and Related DiseasesLiver Diseases and Immunity

Les publications récentes

Accès ouvert 2025 article OpenAlex

Corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States

Cayden Beyer, Michael Fuchs, Mukesh G. Harisinghani, Prasun K. Jalal et autres

OBJECTIVE: The US Food and Drug Administration (FDA) recently approved the first treatment for metabolic dysfunction-associated steatohepatitis (MASH), resmetirom, without clarifying the most effective strategy for diagnosing or monitoring response to therapy. Current standards-of-care (SoC) for Veterans Health Administration (VHA) and Medicare …

gb, us, au (code pays fourni par la source)

2 citations Journal of Medical Economics
2024 article OpenAlex

1410-P: Natural History and Progression of Liver and Cardiac Health in Older Adults, a UK Biobank Study

Charlie Diamond, John McGonigle, Arjun Narayan Ajmer Jayaswal, Sureka Gattu et autres

Surveillance of cardiovascular and renal health is often prioritised in the care of diabetes with liver health often under recognised. We sought to determine how characteristics of the liver and heart progress over time in older adults from the general UK population, …

0 citations Diabetes
Accès ouvert 2024 article OpenAlex

Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH —An individual participant data meta‐analysis

Ferenc Emil Mózes, Jenny Lee, Yasaman Vali, Emmanuel Anandraj Selvaraj et autres

BACKGROUND & AIMS: There is a need to reduce the screen failure rate (SFR) in metabolic dysfunction-associated steatohepatitis (MASH) clinical trials (MASH+F2-3; MASH+F4) and identify people with high-risk MASH (MASH+F2-4) in clinical practice. We aimed to evaluate non-invasive tests (NITs) screening approaches …

gb, nl, fr, ro, tr, my, de, in, it, hk, kr, se, jp, us, ch (code pays fourni par la source)

25 citations Liver International
Accès ouvert 2021 review OpenAlex

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Ferenc Emil Mózes, Jenny Lee, Emmanuel Anandraj Selvaraj, Arjun Narayan Ajmer Jayaswal et autres

OBJECTIVE: Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic fatty liver disease. The aims of this study were to evaluate the individual diagnostic performance of liver stiffness measurement by vibration controlled transient elastography (LSM-VCTE), Fibrosis-4 Index (FIB-4) …

gb, nl, at, fr, ch, it, de, ro, jp, my, ca, hk, cn, kr, tr, in, au, us (code pays fourni par la source)

520 citations Gut
Accès ouvert 2021 review OpenAlex

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

Emmanuel Anandraj Selvaraj, Ferenc Emil Mózes, Arjun Narayan Ajmer Jayaswal, Mohammad Hadi Zafarmand et autres

BACKGROUND AND AIMS: Vibration-controlled transient elastography (VCTE), point shear wave elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic resonance elastography (MRE), and magnetic resonance imaging (MRI) have been proposed as non-invasive tests for patients with non-alcoholic fatty liver disease (NAFLD). This study …

gb, nl, cn, es, us (code pays fourni par la source)

369 citations Journal of Hepatology
Accès ouvert 2020 article OpenAlex

Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus

Arjun Narayan Ajmer Jayaswal, Christina Levick, Jane D Collier, Elizabeth M. Tunnicliffe et autres

Abstract Purpose Direct-acting antiviral therapies (DAAs) for treatment of chronic hepatitis C virus (HCV) have excellent rates of viral eradication, but their effect on regression of liver fibrosis is unclear. The primary aim was to use magnetic resonance imaging (MRI) and spectroscopy …

gb (code pays fourni par la source)

22 citations Abdominal Radiology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.